… Most adverse events have been mild, self limiting, and relatively infrequent. The two main
groups of systemic adverse events we focused on were incontinence and respiratory events. …

… procedural adverse events at the time of injection and at follow-up. Systemic adverse events
… incidence of specific types of adverse events or systemic adverse events and GMFCS level. …

… types of adverse events do not have equal importance for families and clinicians. Studies
that report total adverse event rates may overstate risk by grouping mild adverse events (eg …

… treatment of spasticity in patients with cerebral palsy (CP) have been used for about two
decades. The treatment is considered safe but a low frequency of adverse events (AE) has been …

… ; and (6) details of adverse events – any adverse event that occurred after treatment was …
the incidence of adverse events expressed as a percentage of the overall adverse events). …

… Perioperative adverse events were then compared using multivariate logistic regression
to adjust for any potential residual differences in demographic and comorbid factors after …

… For over 20 years, botulinum toxin has been widely used in clinical practice for treatment of
muscle overactivity in cerebral palsy. Over this period, reports of adverse events have raised …

… adverse events, including stroke, were the focus of most publications, followed by genetic
studies. Malformations, infections, perinatal adverse events … causal pathways of cerebral palsy. …

… what effect adverse events … of adverse events: 31.3% compared with 12.9% for those
children without CP. Both term and preterm infants demonstrated greater rates of adverse events, …

… adverse events (AEs) in hip preservation surgery and has since been utilized in studies
involving lower limb surgery for ambulant and nonambulant children with cerebral palsy (CP). …